Physician profile
Daniel Bintrim
NPI 1639531452
$38,750.76
in general payments reported to CMS, 2019-2025
11 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20K · 2021: $1,883 · 2022: $5,361 · 2023: $7,363 · 2024: $1,087 · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,623 · Food and Beverage: $4,839 · Consulting Fee: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,622.80 |
| Food and Beverage | $4,838.78 |
| Consulting Fee | $615.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $20,020.12 | 2020 | |
| Abbott Laboratories | $8,383.49 | 2021-2025 | Proclaim, Eterna, Infinity |
| Boston Scientific Corporation | $3,989.80 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Medtronic, INC. | $3,444.12 | 2021-2025 | Intellis Adaptivestim, Activos 10 Bone Cement, Inceptiv |
| Nevro Corp. | $2,131.81 | 2020-2024 | Senza |
| Saluda Medical Americas, INC. | $415.08 | 2023-2024 | Evoke Scs, Evoke |
| Globus Medical, INC. | $232.88 | 2025 | Senza |
| Vertos Medical, INC. | $63.76 | 2021-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $30.95 | 2023 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $23.91 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.84 | 2025 | Belbuca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bintrim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.